Reference intervals of salivary cortisol and cortisone and their diagnostic accuracy in Cushing's syndrome.


Journal

European journal of endocrinology
ISSN: 1479-683X
Titre abrégé: Eur J Endocrinol
Pays: England
ID NLM: 9423848

Informations de publication

Date de publication:
Jun 2020
Historique:
received: 29 10 2019
accepted: 26 03 2020
pubmed: 28 3 2020
medline: 8 5 2020
entrez: 28 3 2020
Statut: ppublish

Résumé

The challenge of diagnosing Cushing's syndrome (CS) calls for high precision biochemical screening. This study aimed to establish robust reference intervals for, and compare the diagnostic accuracy of, salivary cortisol and cortisone in late-night samples and after a low-dose (1 mg) dexamethasone suppression test (DST). Saliva samples were collected at 08:00 and 23:00 h, and at 08:00 h, after a DST, from 22 patients with CS and from 155 adult reference subjects. We also collected samples at 20:00 and 22:00 h from 78 of the reference subjects. Salivary cortisol and cortisone were analysed with liquid chromatography-tandem mass spectrometry. The reference intervals were calculated as the 2.5th and 97.5th percentiles of the reference population measurements. Diagnostic accuracies of different tests were compared, based on areas under the receiver-operating characteristic curves. The upper reference limits of salivary cortisol and cortisone at 23:00 h were 3.6 nmol/L and 13.5 nmol/L, respectively. Using these reference limits, CS was detected with a sensitivity (95% CI) of 90% (70-99%) and specificity of 96% (91-98%) for cortisol, and a 100% (84-100%) sensitivity and 95% (90-98%) specificity for cortisone. After DST, cortisol and cortisone upper reference limits were 0.79 nmol/L and 3.5 nmol/L, respectively. CS was detected with 95% (75-100%) sensitivity and 96% (92-99%) specificity with cortisol, and 100% (83-100%) sensitivity and 94% (89-97%) specificity with cortisone. No differences in salivary cortisol or cortisone levels were found between samples collected at 22:00 and 23:00 h. Salivary cortisol and cortisone in late-night samples and after DST showed high accuracy for diagnosing CS, salivary cortisone being slightly, but significantly better.

Identifiants

pubmed: 32213657
doi: 10.1530/EJE-19-0872
pii: EJE-19-0872
doi:
pii:

Substances chimiques

Dexamethasone 7S5I7G3JQL
Cortisone V27W9254FZ
Hydrocortisone WI4X0X7BPJ

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

569-582

Auteurs

Nils Bäcklund (N)

Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.

Göran Brattsand (G)

Department of Medical Biosciences, Clinical Chemistry, Umeå University, Umeå, Sweden.

Marlen Israelsson (M)

Department of Medical Biosciences, Clinical Chemistry, Umeå University, Umeå, Sweden.

Oskar Ragnarsson (O)

Department of Internal Medicine and Clinical Nutrition, Institute of Medicine at Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Department of Endocrinology, Sahlgrenska University Hospital, Gothenburg, Sweden.

Pia Burman (P)

Department of Endocrinology, Skåne University Hospital, University of Lund, Malmö, Sweden.

Britt Edén Engström (B)

Department of Medical Sciences, Endocrinology and Mineral Metabolism, Uppsala University, Uppsala, Sweden.

Charlotte Høybye (C)

Department of Molecular Medicine and Surgery, Patient Area Endocrinology and Nephrology, Inflammation and Infection Theme, Karolinska Institute and Karolinska University Hospital, Stockholm, Sweden.

Katarina Berinder (K)

Department of Molecular Medicine and Surgery, Patient Area Endocrinology and Nephrology, Inflammation and Infection Theme, Karolinska Institute and Karolinska University Hospital, Stockholm, Sweden.

Jeanette Wahlberg (J)

Department of Endocrinology, Department of Medical and Health Sciences, Linköping University, Linköping, Sweden.

Tommy Olsson (T)

Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.

Per Dahlqvist (P)

Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH